Key result
Post-CABG LVEF improvement at six months is linked to ~74% lower all-cause mortality.
Why the study?
Whether short-term improvement in ejection fraction after CABG improves survival outcomes in patients with preoperative left ventricular dysfunction remains uncertain.
Does postoperative LVEF improvement predict better survival outcomes in patients with ischemic cardiomyopathy and preoperative LVEF < 50% undergoing CABG?
Cohort (n=362)
No
Does postoperative LVEF improvement predict better survival outcomes in patients with ischemic cardiomyopathy and preoperative LVEF < 50% undergoing CABG?
Early postoperative LVEF improvement (≥10%) at 6 months following CABG in patients with preoperative LV dysfunction is a strong predictor of long-term overall and event-free survival.
Answers are grounded in this paper and cite their sources.
LVEF improvement ≥10% post-CABG was associated with lower mortality; leaves open whether it should guide management or trial design in ischemic cardiomyopathy.
Left ventricular dysfunction (EF < 50%) is an independent risk factor for undergoing coronary artery bypass grafting (CABG), which has been shown to improve ejection fraction (EF) in patients with ischemic cardiomyopathy. However, whether the short-term improvement in EF can improve survival outcomes remains uncertain. In this retrospective cohort study, we included patients with left ventricular ejection fraction (LVEF) < 50% undergoing CABG from 2013 to 2023. Clinical characteristics were extracted from the data registry. Univariate and multivariate logistic regression analyses identified independent predictors, while Kaplan-Meier analysis with log-rank test compared survival outcomes among LVEF-stratified subgroups. From 2013 to 2023, 362 patients (85.6% male; mean age 58.5) were enrolled. The 5-year Kaplan-Meier estimates for event-free and overall survival were 80.1% and 92.5%, respectively. Landmark analysis showed 72 (19.9%) patients experienced major adverse cardiovascular events, with significant differences between LVEF subgroups (improvement vs. non-improvement; p < 0.001). Multivariable logistic regression identified independent predictors of LVEF improvement: smoking status (p < 0.001), preoperative LVEF < 35% (p < 0.001), dyslipidemia (p = 0.012), and diseased coronary arteries (p < 0.001). Patients with postoperative EF improvement had significantly better overall survival (p < 0.001) and event-free survival (p < 0.001) than those without. The 5-year Kaplan-Meier estimates showed EF improvement early after CABG in patients with preoperative cardiac dysfunction predicted better survival. This highlights the need for closer postoperative monitoring and proactive management in this population. Additionally, interventions with proactive patient education should address factors causing postoperative LVEF non-improvement.
No takes yet. Share an insight, caveat, or question.
He et al. (2026) conducted a cohort in Ischemic cardiomyopathy with preoperative left ventricular dysfunction (n=362). Postoperative LVEF improvement (≥ 10% increase) vs. Postoperative LVEF non-improvement was evaluated on All-cause mortality (HR 0.261, 95% CI 0.114-0.600, p=< 0.001). Postoperative left ventricular ejection fraction improvement of ≥10% at 6 months after coronary artery bypass grafting reduced the risk of all-cause mortality compared to non-improvement.
Synapse has enriched 10 related papers. Consider them for comparative context: